Poster Combination therapy with anti-PD-1 and YH29407, a novel IDO1 inhibitor, enhances T cell-mediated antitumor immunity in MC38 tumor-bearing mice
페이지 정보
작성자 DAAN
조회 281회 작성일 24-02-16 16:24
조회 281회 작성일 24-02-16 16:24
본문
| Journal | AACR |
|---|---|
| Name | 표경호, 김동권, 신춘봉 |
| Year | 2022 |
첨부파일
-
2022-AACR-Poster-Yuhan.pdf (3.5M)
0회 다운로드 | DATE : 2024-02-16 16:24:25
- 이전글Combinatorial activity of amivantamab and pembrolizumab in head and neck squamous cell carcinoma and lung squamous cell carcinoma expressing wild-type EGFR and MET 23.04.18
- 다음글Mechanism study of CJRS-10671 and CJRS-10672 on PDX CD34-NSG mice with investigation of tumor microenvironment and scRNA sequencing 24.02.16